نتایج جستجو برای: caspase 3

تعداد نتایج: 1825812  

Journal: :research in pharmaceutical sciences 0
somayeh atari-hajipirloo 1department of biochemistry , student research committee,urmia university of medical sciences, urmia, i.r. iran. saba nikanfar 2department of biochemistry, urmia university of medical sciences, urmia, i.r. iran. amir heydari 3department of pharmacology, cellular and molecular research center, urmia university of medical sciences, urmia, i.r. iran. fatemeh kheradmand 4department of clinicalbiochemistry, cellular and molecular and solid tumor research center, urmia university of medical sciences, urmia, i.r. iran.

mono-targeting by imatinib as a main antitumor agent does not always accomplish complete cancer suppression. 2,5-dimethyl-celecoxib (dmc) is a close structural analog of the selective cyclooxygenase-2 (cox-2) inhibitor, celecoxib, that lacks cox-2 inhibitory function. in this study, we aimed to show the apoptotic effects of imatinib in combination with dmc in human ht-29 colorectal cancer (crc)...

Journal: :Cancer Biology & Therapy 2011

Journal: :Indian Journal of Animal Sciences 2022

The present study was conducted to evaluate the expression of caspase-3, caspase-9, growth differentiation factor-9 (GDF-9) and insulin factor-1 (IGF-1) genes in oocytes cultured vitro with optimum elevated doses amphiregulin (50 ng 150 ng), neuregulin-1 (25 ng) tumor necrosis factor-α during maturation based on results effects AREG or NRG-1 TNF-α concentration which caused significant effect, ...

Caspase-3, one of the dominant effectors caspases, is activated in almost every model of apoptosis with various signaling pathways. Hence, inhibition of caspase-3 has become an attractive target in the treatment of neurodegenerative diseases. Caspase-3 inhibitory activities of some 1,2-benzisothiazol-3-one derivatives were modeled by quantitative structure–activity relationship (QSAR) using ste...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید